Intellectual Property Industries

BiologicsHQ

Information contained in the BiologicsHQ database relates to FDA-approved drug products listed in the CDER Purple Book
Read More

Ten Reasons Companies Need to Stay on Top of Recent Patent Trends

July 29, 2022

1min

Intellectual Property and Advertising Considerations for Esports

March 08, 2022

1min

Identical Marks, Identical Types of Products: Not Enough to Presume Confusion

October 15, 2020

1min

Biosimilars Contested Proceedings, Litigation and Patent Law

January 22 - 24, 2020 Informa’s Specialty Therapies and Biosimilars Congress

The Top Copyright Issues Facing Nonprofits

September 17, 2019 Washington, DC - A Complimentary Venable LLP Seminar/Webcast

BTI Consulting Group Recognizes Venable Among the Best of the Best Law Firms in IP Litigation

October 27, 2021

1min

Patent Trial and Appeal Board Denies Institution of Inter Partes Review of Novartis’s Entresto® Patent on Combination of Valsartan and Sacubitril

February 16, 2021

1min

Center for Biosimilars Quotes Ha Kung Wong on Insulin Product’s Progress Along 351(k) Biologics License Application Pathway

June 15, 2020

2min